Scott E. Hensley, Ph.D.
Affiliations: | 2006 | University of Pennsylvania, Philadelphia, PA, United States |
Area:
Immunology, Molecular Biology, Microbiology Biology, Virology BiologyGoogle:
"Scott Hensley"Parents
Sign in to add mentor| Hildegund Ertl | grad student | 2006 | Penn | |
| (The effects of type I interferons following vaccination with adenovirus vectors.) | ||||
| Jonathan Wilson Yewdell | post-doc | 2005-2010 | University of Pennsylvania Medical School | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chong EA, Kumashie KG, Chong ER, et al. (2024) Immunologic predictors of vaccine responsiveness in patients with lymphoma and CLL. The Journal of Infectious Diseases |
| Johnston TS, Li SH, Painter MM, et al. (2024) Immunological imprinting shapes the specificity of human antibody responses against SARS-CoV-2 variants. Medrxiv : the Preprint Server For Health Sciences |
| Kim K, Gouma S, Vieira MC, et al. (2023) Measures of population immunity can predict the dominant clade of influenza A (H3N2) and reveal age-associated differences in susceptibility and specificity. Medrxiv : the Preprint Server For Health Sciences |
| Painter MM, Johnston TS, Lundgreen KA, et al. (2023) Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection. Nature Immunology |
| Bolton MJ, Santos JJS, Arevalo CP, et al. (2023) IgG3 subclass antibodies recognize antigenically drifted influenza viruses and SARS-CoV-2 variants through efficient bivalent binding. Proceedings of the National Academy of Sciences of the United States of America. 120: e2216521120 |
| Furey C, Ye N, Kercher L, et al. (2023) Development of a nucleoside-modified mRNA vaccine against clade 2.3.4.4b H5 highly pathogenic avian influenza virus. Biorxiv : the Preprint Server For Biology |
| Painter MM, Johnston TS, Lundgreen KA, et al. (2023) Prior vaccination enhances immune responses during SARS-CoV-2 breakthrough infection with early activation of memory T cells followed by production of potent neutralizing antibodies. Biorxiv : the Preprint Server For Biology |
| Gouma S, Furey C, Santos JJS, et al. (2022) Nucleoside-Modified mRNA-Based Influenza Vaccines Circumvent Problems Associated with H3N2 Vaccine Strain Egg Adaptation. Journal of Virology. e0172322 |
| Arevalo CP, Bolton MJ, Le Sage V, et al. (2022) A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes. Science (New York, N.Y.). 378: 899-904 |
| Flannery DD, Gouma S, Dhudasia MB, et al. (2022) Comparison of Maternal and Neonatal Antibody Levels After COVID-19 Vaccination vs SARS-CoV-2 Infection. Jama Network Open. 5: e2240993 |